Professional Education & Development
Professional Education & Development
Professional Education and Development initiatives for students are essential components of their academic journey, preparing them for diverse career paths beyond academia. These initiatives encompass workshops, seminars, and mentorship programs designed to enhance students’ skills, broaden their perspectives, and facilitate informed career decision-making. From industry field trips to networking events with leaders in various fields, these initiatives empower students to explore their interests, identify potential career trajectories, and develop the competencies necessary for success in both academic and non-academic settings. By nurturing a culture of career exploration and providing tailored support, these initiatives ensure that Ph.D. and M.D./Ph.D students are equipped to thrive in their chosen career paths and make meaningful contributions to society.
Upcoming Events
2023 Distinguished Alumni Award Recipient Special Lecture: Professor Jonathan Roiser, UCL– April 16, 2024
AZ UK Career Development and Exploration Initiative– April 17-18, 2024
Past Events
Coming soon.
2023 DISTINGUISHED ALUMNI AWARD RECIPIENT SPECIAL LECTURE: PROFESSOR JONATHAN ROISER, UCL
Event Description
The International Biomedical Research Alliance (IBRA) and University College London (UCL) cordially invite you to join us on Tuesday, April 16, 2024, from 11:00 AM to 3:30 PM GMT, as we celebrate our 2023 Distinguished Alumni Award recipient, Professor Jonathan Roiser.
Attendees are welcome to participate in a guided tour of UCL, offering insights into their history and innovations. This event promises to be an inspiring and intellectually enriching experience, bringing together alumni, faculty, and esteemed guests. Following the tour, attendees are invited to lunch.
After the lecture, there will be a delightful tea and dessert, providing an opportunity for networking and further discussions.
About Professor Jonathan Roiser
Prof. Jonathan Roiser was the first Scholar to graduate from the University of Cambridge arm of the NIH Oxford-Cambridge Scholars Program in 2005, having joined OxCam as an Advanced Scholar part-way through his PhD, which was funded by the UK Medical Research Council. Together with his mentors, Prof. Barbara Sahakian and Dr. Wayne Drevets, they planned a highly complex psychopharmacological neuroimaging experiment to understand how serotonin modulates the brain’s processing of emotion in depression.
After graduation, Jonathan returned to London in 2005 for a post-doctoral position at the Wellcome Trust Centre for Neuroimaging at University College London (UCL) where he was mentored by some of the world’s leading experts in neuroimaging. Impressively, after only two years, he obtained a faculty position at the UCL Institute of Cognitive Neuroscience, where he founded the Neuroscience and Mental Health group which he continues to direct today.
In 2013, Jonathan became the youngest ever Wellcome Trust Senior Investigator with a £1 million grant, allowing him to undertake an extensive research program focusing on motivational dysfunction in depression and novel treatments. He has become a pioneer and international leader in the biological psychiatry field, especially in the burgeoning area of computational psychiatry. Jonathan founded and directs two PhD programmes – the UCL-NIMH Joint Doctoral Training Program in Neuroscience, and the UCL-Wellcome 4-year PhD in Mental Health Science.
Event Countdown
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
AZ UK Career Development and Exploration Initiative
Event Description
The International Biomedical Research Alliance (IBRA) and AstraZeneca invite NIH Oxford-Cambridge Scholars based in the UK to participate in our first Career Development and Exploration Initiative of 2024, at the AstraZeneca Discovery Center (DISC), a cutting-edge research and development facility in Cambridge, UK from April 17-18, 2024.
This unique focused-interest opportunity sponsored by AstraZeneca, and hosted by Dr. Andreas Dannhorn and our distinguished Alumni Director Dr. Coralie Viollet, (NIH-Oxford Wellcome Trust ’11) & will provide Scholars with an immersive experience in the vibrant biotech hub of Cambridge, UK, offering unparalleled insights into the dynamic landscape of pharmaceutical innovation. Through engaging talks, networking sessions, and expert-guided tours, participants gain invaluable exposure to state-of-the-art research methodologies and the collaborative ethos propelling scientific advancement. At every turn, the AstraZeneca Global R&D campus showcases the unwavering passion and commitment of scientists dedicated to addressing some of the world’s most urgent medical challenges through breakthrough therapies and transformative technologies.
Scholars in the UK interested in one or more of AstraZeneca’s therapy areas (Oncology, BioPharmaceuticals, Cardiovascular, Renal and Metabolism, Respiratory & Immunology, Vaccines and Immune Therapies, and Rare Disease) are especially encouraged to apply as Scholars will have the opportunity to give a 10-minute presentation of their work to distinguished scientists and researchers at AstraZeneca. Please complete the form below by April 5, 2024, at 5:00 PM ET after reading the full instructions.
Scholars are required to:
- Be in good standing with the program. Please contact Dr. Collins or Dr. Porter if you are uncertain of your status.
- Adhere to the rules set forth in the IBRA Code of Conduct
- Be located in the UK; travel support (including accommodations) is available for students selected from the University of Oxford.
- Prepare and present a 10-minute talk on their research; please ensure all information shared is suitable for public presentation.
- Scholars will have the opportunity to present for feedback to Dr. Swafford prior to the trip, so presentations should be provided to IBRA for review by April 8th, 2024.
- Obtain approval for travel from their UK PI by 12:00 PM BST on April 8th, 2024: Please have the PI email Alex Ambrico (ajambrico@biomedalliance.org) stating “I have no objections to [Your Name] traveling to AstraZeneca from April 17-18th, 2024. I will review their presentation materials before the trip to ensure the presentation is acceptable for public viewing.”
- Complete a feedback survey following the trip
About The Discovery Centre (DISC)
The DISC is a state-of-the-art global R&D facility opened in 2021 and located in the heart of the Cambridge Biomedical Campus in Cambridge, UK, one of the most exciting bioscience hotspots in the world. At the DISC, the largest research and development centre in the UK, more than 2,300 scientists work in drug discovery and development across therapy areas, each playing a central role in AstraZeneca’s mission to deliver life-changing medicines to patients. The DISC is uniquely designed to strengthen collaboration, promote openness, and improve the sustainability of every aspect of our science and business operations.
Event Countdown
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)